Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 1(13), 2023
DOI: 10.1038/s41408-023-00923-6
Links
Tools
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study
Journal article published in 2023 by
Thomas Martin 
,
Meletios-Athanasios Dimopoulos ,
Joseph Mikhael ,
Kwee Yong ,
Marcelo Capra,
Thierry Facon,
Roman Hajek ,
Ivan Špička,
Ross Baker,
Kihyun Kim,
Gracia Martinez,
Chang-Ki Min,
Ludek Pour,
Xavier Leleu ,
Albert Oriol
and other authors.
,
Meletios-Athanasios Dimopoulos ,
Joseph Mikhael ,
Kwee Yong ,
Marcelo Capra,
Thierry Facon,
Roman Hajek ,
Ivan Špička,
Ross Baker,
Kihyun Kim,
Gracia Martinez,
Chang-Ki Min,
Ludek Pour,
Xavier Leleu ,
Albert Oriol
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 